StemCells Inc. (STEM) reported a fourth-quarter net loss of $2.76 million or $0.07 per share, compared to a net loss of $7.21 million or $0.47 per share in the fourth quarter of 2011.
Loss from operations in the fourth quarter of 2012 was $6,793,000, which was 7% lower compared to the fourth quarter of 2011.
Total revenue during the fourth quarter of 2012 was $211,000, compared to $541,000 in the same period of 2011. The decline was primarily due to higher revenue from licensing agreements in 2011. Total operating expenses in the fourth quarter of 2012 were $6,949,000, an 11% decrease compared to the fourth quarter of 2011.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.14 per share on revenues of $310 thousand for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com